Pacific Biosciences

The VGP released its first 15 high-quality reference genome assemblies today, which are part of the project's first phase to sequence 260 vertebrate genomes.

The firm will sell more than 14 million shares of its common stock for $4.25 per share.

The firm did not disclose how many shares it planned to sell or how much money it expects to raise.

The firm plans to release an upgrade that will improve read lengths and throughput, with an eye toward being a player in the population sequencing market.

PacBio's revenues increased to $21.6 million, but missed analysts average estimate of $23.8 million.

The Beijing-based firm said it will use the funding for research and development, to obtain additional intellectual property, and to pursue its strategic goals.

Natera led the Index with a 61 percent increase in stock price, driven by the firm's announcement that it was entering the transplantation market.

Pages

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.